Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7440
-0.0263 (-3.41%)
At close: Sep 24, 2026, 4:00 PM EDT
0.7353
-0.0087 (-1.17%)
After-hours: Sep 24, 2026, 6:36 PM EDT
Rein Therapeutics Employees
Rein Therapeutics had 10 employees as of December 31, 2025. The number of employees decreased by 1 or -9.09% compared to the previous year.
Employees
10
Change (1Y)
-1
Growth (1Y)
-9.09%
Revenue / Employee
n/a
Profits / Employee
-$4,976,100
Market Cap
64.18M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 10 | -1 | -9.09% |
| Dec 31, 2024 | 11 | -4 | -26.67% |
| Dec 31, 2023 | 15 | 9 | 150.00% |
| Dec 31, 2022 | 6 | -3 | -33.33% |
| Dec 31, 2021 | 9 | 1 | 12.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Gossamer Bio | 162 |
| Alps Group | 93 |
| XBiotech | 87 |
| MindWalk Holdings | 77 |
| Connect Biopharma Holdings | 64 |
| Pliant Therapeutics | 49 |
| MiNK Therapeutics | 15 |
RNTX News
- 10 days ago - Rein Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 13 days ago - Rein Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 13 days ago - Rein Therapeutics Slides: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Filings
- 20 days ago - Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress - GlobeNewsWire
- 21 days ago - Rein Therapeutics to Present at Upcoming September Investor Conferences - GlobeNewsWire
- 5 weeks ago - Rein Therapeutics granted Fast Track designation for LTI-03 - TheFly
- 5 weeks ago - Rein Therapeutics Receives U.S. FDA Fast Track Designation for LTI-03 in Idiopathic Pulmonary Fibrosis - GlobeNewsWire
- 5 weeks ago - Rein Therapeutics Slides: Corporate presentation - Filings